An unusual side effect of amphetamine-like drugs is described. A patient with acute cardiomyopathy was discovered to have been taking Fenfluramine and Mazindol at the prescribed dose. Within a week after abstention from the drugs and appropriate cardiac treatment her cardiomyopathy resolved. The authors suggest that this effect is due to the combination of the two drugs and represents a drug interaction.
Get full access to this article
View all access options for this article.
References
1.
PinderR. M.BrogdenR. N.SawyerP. R.SpeightT. M., and AveryG. S.Fenfluarmine: A Review of Its Pharmacological Properties and Therapeutic Efficacy in Obesity, Drugs, 10, pp. 241–323, 1975.
2.
HadlerA. J., Mazindol, A New Non-Amphetamine Anorexigenic Agent, Journal of Clinical Pharmacology and New Drugs, pp. 453–458, 1972.
3.
SmithH. J.RocheA. H. G.JaguschM. F., and HendersonP. B.Cardiomyopathy Associated with Amphetamine Administration, American Heart Journal, 91, pp. 792–797, 1976.
4.
CallT. D.HartneckJ.DickinsonW. A.HartmanC. W., and BarrelA. G.Acute Cardiomyopathy Secondary to Intravenous Amphetamine Abuse, Annals of Internal Medicine, 97, pp. 559–560, 1982.
5.
CroftC. H.FirthB. G., and HillisD. L.Propylhexedrine Induced Left Ventricular Dysfunction, Annals of Internal Medicine, 97, pp. 560–561, 1982.
